Calidi Biotherapeutics, Inc. (CLDI)
NYSE: CLDI · Biological Products, (No Diagnostic Substances) · filing with the SEC since 2021
Income statement, as filed
In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Report filed | Mar 27, 2026 | Mar 31, 2025 | Mar 15, 2024 | Mar 31, 2023 | Mar 31, 2022 |
| Revenue | · | · | · | 45,000 | · |
| Research and development | 9,737,000 | 8,878,000 | 13,008,000 | 7,257,000 | · |
| Selling, general and administrative | 10,503,000 | 12,898,000 | 15,984,000 | 15,902,000 | · |
| Total operating expenses | 20,240,000 | 21,776,000 | 28,992,000 | 23,173,000r | · |
| Operating income | -20,240,000 | -21,776,000 | -28,992,000 | -23,128,000r | · |
| Interest expense | 100,000 | 700,000 | 1,100,000 | 200,000 | · |
| Other income (expense), net | 103,000 | 9,000 | -51,000 | -5,000 | · |
| Total non-operating income (expense) | 192,000 | -419,000 | -208,000 | -2,288,000r | · |
| Income before income taxes | -20,048,000 | -22,195,000 | -29,200,000 | -25,416,000r | · |
| Income tax expense | 15,000 | 14,000 | 16,000 | 11,000r | · |
| Net income including non-controlling interests | -20,063,000 | -22,209,000 | -29,216,000 | · | · |
| Net income to non-controlling interests | -157,000 | -66,000 | · | · | · |
| Net income | -19,906,000 | -22,143,000 | -29,216,000 | -25,427,000r | · |
| Net income to common shareholders | -25,579,000 | -23,814,000 | -29,216,000 | 1,071,338 | · |
| Earnings per share, basic | -5.95 | -35.70r | -17.33r | 2.99 | · |
| Earnings per share, diluted | -5.95 | -35.70r | -17.33r | 2.99 | · |
| Weighted average shares, basic | 4,302 | 667r | 1,686,000r | 8,505,000 | · |
| Weighted average shares, diluted | 4,302,000b | 667,000rb | 1,686,000r | 8,505,000 | · |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseDebtOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income to non-controlling interests the share that belongs to minority holders
us-gaap:NetIncomeLossAttributableToNoncontrollingInterestNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding